Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Alcohol Craving and Drinking
NCT00006203Phase 4Completed
- Sponsor
- Brown University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol use disorder (AUD) comparing Naltrexone Arm with Placebo Arm (2 arms). Primary endpoints: Alcohol Craving at 3 weeks, Drinking Rates at 3 weeks and 1 more. Status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00006203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006203.